Several leading UK universities are set to benefit from a £35m ($56m) investment by Cancer Research UK and the Engineering and Physical Sciences Research Council (EPSRC) into cancer imaging centres.
The centres, which provide invaluable feedback from patients as to how the body responds to cancer therapies, will enable researchers to develop treatments faster with a view to transferring the technologies more rapidly into real-world products.
The universities set to benefit are:

  • Cambridge and Manchester (collaboration)
  • Oxford…

    Subscribe to go deeper

    GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

    Not sure if you have a subscription?